Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

ConditionsEye Diseases Retinitis Pigmentosa Diabetic Retinopathy Macular Degeneration Traumatic Optic Neuropathy Optic Atrophy

Trial statusRecruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorThe Foundation for Orthopaedics and Regenerative Medicine

About this trial

This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of non-arteritic ischemic optic neuropathy

Eligibility criteria

Qualifiers

Diagnosis of NAION (non-arteritic ischemic optic neuropathy)

Understanding and willingness to sign a written informed consent document

Disqualifiers

Active infection

Active cancer

Chronic multisystem organ failure

Pregnancy

Trial design

Treatments tested in this trial

AlloRx

Treatment groups

20 Participants

are divided into 1 treatment group

Locations

Antigua and Barbuda

Medical Surgical Associates Center St John's Antigua and Barbuda

Argentina

Center for Investigation in Tissue Engineering and Cellular Therapy Buenos Aires Argentina

Sponsors and collaborators

The Foundation for Orthopaedics and Regenerative Medicine

Lead sponsor

Source ClinicalTrials.gov